Breast milk and Group B streptococcal infection: Vector of transmission or vehicle for protection?

Vaccine

Volumn 32, Issue 26, 2014, Pages 3128-3132

  Le Doare, Kirsty ^a,b,c   Kampmann, Beate ^a,c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c MRC Unit   (Gambia)

Author keywords

Antibody; Breast milk; Group B streptococcus; Immunity; Vaccination

Indexed keywords

ANTIBODY; OLIGOSACCHARIDE;

BIRTH; BREAST MILK; DISEASE TRANSMISSION; GROUP B STREPTOCOCCAL INFECTION; HIGH RISK POPULATION; HUMAN; IMMUNITY; IMMUNIZATION; INFANT FEEDING; INFANT MORTALITY; INTESTINE FLORA; MORBIDITY; NEWBORN DISEASE; PREMATURITY; PRIORITY JOURNAL; PROTECTION; RECTUM; REVIEW; SEROTYPE; VAGINA;

EID: 84900460045     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.020     Document Type: Review

References (83)

1. Nocard N., Mollereau R. Sur une mammite contagieuse des vaches laitieres. Ann Inst Pasteur 1887, 1:109-126.
2. Lancefield R.H.R. The serological differentiation of pathogenic and nonpathogenic strains of hemolytic streptococci from parturient women. J Exp Med 1935, 61:335-349.
3. Fry R. Fatal infections by hemolytic streptococcus group B. Lancet 1938;1:199-201.
4. Hood M., Janney A., Dameron G. Beta hemolytic streptococcus group B associated with problems of the perinatal period. Am J Obstetr Gynecol 1961 Oct, 82:809-818.
5. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 1973;82(4):724-9.
6. Fluegge K., Siedler A., Heinrich B., Schulte-Moenting J., Moennig M.J., Bartels D.B., et al. Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics 2006, 117(June (6)):e1139-e1145.
7. Kalliola S., Vuopio-Varkila J., Takala A.K., Eskola J. Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J 1999, 18(September (9)):806-810.
8. Neto M.T. Group B streptococcal disease in Portuguese infants younger than 90 days. Arch Dis Child Fetal Neonatal Ed 2008, 93(2):F90-F93.
9. Filleron A., Lombard F., Jacquot A., Jumas-Bilak E., Rodiere M., Cambonie G., et al. Group B streptococci in milk and late neonatal infections: an analysis of cases in the literature. Arch Dis Child Fetal Neonatal Ed 2013, 99(August).
10. Weisner A.M., Johnson A.P., Lamagni T.L., Arnold E., Warner M., Heath P.T., et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 2004, 38(May (9)):1203-1208.
11. Phares C.R., Lynfield R., Farley M.M., Mohle-Boetani J., Harrison L.H., Petit S., et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299(May (17)):2056-2065.
12. Heath P.T., Balfour G., Weisner A.M., Efstratiou A., Lamagni T.L., Tighe H., et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004, 363(January (9405)):292-294.
13. Zangwill K.M., Schuchat A., Wenger J.D. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ 1992, 41(November (6)):25-32.
14. Prevention CfDCa. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2012. Atlanta; 2012 [accessed: 19.03.14]. Available from:. http://www.cdc.gov/abcs/reports-findings/survreports/gbs12.html.
15. Gray K.J., Bennett S.L., French N., Phiri A.J., Graham S.M. Invasive group B streptococcal infection in infants, Malawi. Em Infect Dis 2007, 13(February (2)):223-229.
16. Berkley J.A., Lowe B.S., Mwangi I., Williams T., Bauni E., Mwarumba S., et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005, 352(January (1)):39-47.
17. Sigauque B., Roca A., Mandomando I., Morais L., Quinto L., Sacarlal J., et al. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J 2009, 28(February (2)):108-113.
18. Darmstadt G.L., Saha S.K., Choi Y., El Arifeen S., Ahmed N.U., Bari S., et al. Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study. J Infect Dis 2009, 200(September (6)):906-915.
19. Kuruvilla K.A., Thomas N., Jesudasan M.V., Jana A.K. Neonatal Group B Streptococcal bacteraemia in India: ten years' experience. Acta Paediatr 1999, 88(September (9)):1031-1032.
20. Lim N.L., Wong Y.H., Boo N.Y., Kasim M.S., Chor C.Y. Bacteraemic infections in a neonatal intensive care unit-a nine-month survey. Med J Malaysia 1995, 50(March (1)):59-63.
21. Dagnew A.F., Cunnington M.C., Dube Q., Edwards M.S., French N., Heyderman R.S., et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis 2012, 55(July (1)):91-102.
22. Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 2010;19(59(RR-10)):1-36.
23. Jones N., Oliver K., Jones Y., Haines A., Crook D. Carriage of group B streptococcus in pregnant women from Oxford, UK. J Clin Pathol 2006, 59(April (4)):363-366.
24. Bergeron M.G., Ke D., Menard C., Picard F.J., Gagnon M., Bernier M., et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000, 343(July (3)):175-179.
25. Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 2001;323(7312):533-6.
26. Kotiw M., Zhang G.W., Daggard G., Reiss-Levy E., Tapsall J.W., Numa A. Late-onset and recurrent neonatal Group B streptococcal disease associated with breast-milk transmission. Pediatr Dev Pathol 2003, 6(May-June (3)):251-256.
27. Butter M.D.C. Streptococcus agalactiae as a cause of meningitis in the newborn and bacteraemia in adults. Antonie Van Leeuwenhoek 1967, 33(4):439.
28. Burianova I., Paulova M., Cermak P., Janota J. Group B streptococcus colonization of breast milk of group B streptococcus positive mothers. J Hum Lact 2013, 29(November (4)):586-590.
29. Kvist L.J., Larsson B.W., Hall-Lord M.L., Steen A., Schalen C. The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment. Int Breastfeed J 2008, 3:6.
30. Kubin V., Mrastikova H., Paulova M., Motlova J., Franek J. Group B streptococci in the milk of lactating mothers. Zentralbl Bakteriol Mikrobiol Hyg A 1987, 265(June (1-2)):210-217.
31. Schanler R.J., Lau C., Hurst N.M., Smith E.O. Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics 2005, 116(August (2)):400-406.
32. Serafini A.B., Andre M.C., Rodrigues M.A., Kipnis A., Carvalho C.O., Campos M.R., et al. Microbiological quality of human milk from a Brazilian milk bank. Rev Saude Publica 2003, 37(December (6)):775-779.
33. Jeurink P.V., van Bergenhenegouwen J., Jimenez E., Knippels L.M., Fernandez L., Garssen J., et al. Human milk: a source of more life than we imagine. Benef Microbes 2013, 4(March (1)):17-30.
34. Evans T.J., Ryley H.C., Neale L.M., Dodge J.A., Lewarne V.M. Effect of storage and heat on antimicrobial proteins in human milk. Arch Dis Child 1978, 53(March (3)):239-241.
35. Ewaschuk J.B., Unger S., O'Connor D.L., Stone D., Harvey S., Clandinin M.T., et al. Effect of pasteurization on selected immune components of donated human breast milk. J Perinatol 2011, 31(September (9)):593-598.
36. Christen L., Lai C.T., Hartmann B., Hartmann P.E., Geddes D.T. The effect of UV-C pasteurization on bacteriostatic properties and immunological proteins of donor human milk. PLoS ONE 2013, 8(12):e85867.
37. Davanzo R., De Cunto A., Travan L., Bacolla G., Creti R., Demarini S. To feed or not to feed? Case presentation and best practice guidance for human milk feeding and group B streptococcus in developed countries. J Hum Lact 2013, 29(November (4)):452-457.
38. Cossey V., Vanhole C., Eerdekens A., Rayyan M., Fieuws S., Schuermans A. Pasteurization of mother's own milk for preterm infants does not reduce the incidence of late-onset sepsis. Neonatology 2013, 103(3):170-176.
39. Jones C.A. Maternal transmission of infectious pathogens in breast milk. J Paediatr Child Health 2001, 37(December (6)):576-582.
40. Lawrence R.M., Lawrence R.A. Breast milk and infection. Clin Perinatol 2004, 31(September (3)):501-528.
41. Perez P.F., Dore J., Leclerc M., Levenez F., Benyacoub J., Serrant P., et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells?. Pediatrics 2007, 119(March (3)):e724-e732.
42. Albesharat R., Ehrmann M.A., Korakli M., Yazaji S., Vogel R.F. Phenotypic and genotypic analyses of lactic acid bacteria in local fermented food, breast milk and faeces of mothers and their babies. Syst Appl Microbiol 2011, 34(April (2)):148-155.
43. Gagneur A., Hery-Arnaud G., Croly-Labourdette S., Gremmo-Feger G., Vallet S., Sizun J., et al. Infected breast milk associated with late-onset and recurrent group B streptococcal infection in neonatal twins: a genetic analysis. Eur J Pediatr 2009, 168(September (9)):1155-1158.
44. Olver W.J., Bond D.W., Boswell T.C., Watkin S.L. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed 2000, 83(July (1)):F48-F49.
45. Goldman A, Chheda, S, Keeney, SE. In: Polin RA, Fox WW, Abman SH, editors. Fetal and neonatal physiology, 3rd ed., vol. 2. Elsevier, Philadelphia; 2002. p. 2022-32 [chapter 184].
46. Hanson L.A., Korotkova M. The role of breastfeeding in prevention of neonatal infection. Semin Neonatol 2002, 7(August (4)):275-281.
47. Labbok M.H., Clark D., Goldman A.S. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol. 2004, 4(July (7)):565-572.
48. Vassilev T.L., Veleva K.V. Natural polyreactive IgA and IgM autoantibodies in human colostrum. Scand J Immunol 1996, 44(November (5)):535-539.
49. Newburg D.S., Walker W.A. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 2007, 61(January (1)):2-8.
50. Morrow A.L., Ruiz-Palacios G.M., Altaye M., Jiang X., Guerrero M.L., Meinzen-Derr J.K., et al. Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants. Adv Exp Med Biol 2004, 554:443-446.
51. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7(May (5)):379-390.
52. LeBouder E., Rey-Nores J.E., Raby A.C., Affolter M., Vidal K., Thornton C.A., et al. Modulation of neonatal microbial recognition: TLR-mediated innate immune responses are specifically and differentially modulated by human milk. J Immunol 2006, 176(March (6)):3742-3752.
53. Isaacs C.E., Litov R.E., Thormar H. Antimicrobial activity of lipids added to human milk, infant formula, and bovine milk. J Nutr Biochem 1995, 6(July (7)):362-366.
54. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007, 25(July (30)):5467-5484.
55. Goldman A.S. Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective. J Nutr 2000, 130(February (2S Suppl)):426S-431S.
56. Krakauer R., Zinneman H.H., Hong R. Deficiency of secretory Ig-A and intestinal malabsorption. Am J Gastroenterol 1975, 64(October (4)):319-323.
57. Dickinson E.C., Gorga J.C., Garrett M., Tuncer R., Boyle P., Watkins S.C., et al. Immunoglobulin A supplementation abrogates bacterial translocation and preserves the architecture of the intestinal epithelium. Surgery 1998, 124(August (2)):284-290.
58. Walterspiel J.N., Morrow A.L., Guerrero M.L., Ruiz-Palacios G.M., Pickering L.K. Secretory anti-Giardia lamblia antibodies in human milk: protective effect against diarrhea. Pediatrics 1994, 93(January (1)):28-31.
59. Edmond K., Zaidi A. New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med 2010, 7(March (3)):e1000213.
60. Cruz J.R., Gil L., Cano F., Caceres P., Pareja G. Breast milk anti-Escherichia coli heat-labile toxin IgA antibodies protect against toxin-induced infantile diarrhea. Acta Paediatr Scand 1988, 77(September (5)):658-662.
61. Stephens S., Kennedy C.R., Lakhani P.K., Brenner M.K. In-vivo immune responses of breast- and bottle-fed infants to tetanus toxoid antigen and to normal gut flora. Acta Paediatr Scand. 1984, 73(July (4)):426-432.
62. Weaver LT, Wadd N, Taylor CE, Greenwell J, Toms GL. The ontogeny of serum IgA in the newborn. Pediatr Allergy Immunol 1991;2:2-75.
63. Jatsyk G.V., Kuvaeva I.B., Gribakin S.G. Immunological protection of the neonatal gastrointestinal tract: the importance of breast feeding. Acta Paediatr Scand 1985, 74(March (2)):246-249.
64. Edén CS, Carlsson B, Hanson LA, Jann B, Jann K, Korhonen T, et al. Anti-piliantibodies in breast milk. Lancet 1979.ii:1235.
65. Aniansson G., Andersson B., Lindstedt R., Svanborg C. Anti-adhesive activity of human casein against Streptococcus pneumoniae and Haemophilus influenzae. Microb Pathog 1990, 8(May (5)):315-323.
66. Van de Perre P. Transfer of antibody via mother's milk. Vaccine 2003, 21(July (24)):3374-3376.
67. Hahn-Zoric M., Carlsson B., Jeansson S., Ekre H.P., Osterhaus A.D., Roberton D., et al. Anti-idiotypic antibodies to poliovirus antibodies in commercial immunoglobulin preparations, human serum, and milk. Pediatr Res 1993, 33(May (5)):475-480.
68. Shahid N.S., Steinhoff M.C., Roy E., Begum T., Thompson C.M., Siber G.R. Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation. Vaccine 2002, 20(May (17-18)):2404-2409.
69. Munoz F.M., Englund J.A., Cheesman C.C., Maccato M.L., Pinell P.M., Nahm M.H., et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 2001, 20(December (5-6)):826-837.
70. Weisman L.E., Dobson F.M. The potential impact of group B streptococcal antibodies in breast milk. Adv Exp Med Biol 1991, 310:345-351.
71. Lagergard T., Thiringer K., Wassen L., Schneerson R., Trollfors B. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk. Eur J Pediatr 1992, 151(February (2)):98-102.
72. Edwards M.S., Munoz F.M., Baker C.J. Antibodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infect Dis J 2004, 23(October (10)):961-963.
73. Berardi A., Rossi C., Creti R., China M., Gherardi G., Venturelli C., et al. Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. J Pediatr 2013, 163(October (4)). 1099-104.e1.
74. Heiman HS, Weisman LE. Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III group B streptococcal infection. Pediatr Res 1989;26(6):629-32.
75. Gray B.M., Egan M.L., Pritchard D.G. Specificity of monoclonal antibodies against group B streptococcus type II and inhibition of their binding by human secretions. Pediatr Res 1988, 24(July (1)):68-72.
76. Andersson B., Porras O., Hanson L.A., Lagergard T., Svanborg-Eden C. Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. J Infect Dis 1986, 153(February (2)):232-237.
77. Cravioto A., Tello A., Villafan H., Ruiz J., del Vedovo S., Neeser J.R. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J Infect Dis 1991, 163(June (6)):1247-1255.
78. Ruiz-Palacios G.M., Calva J.J., Pickering L.K., Lopez-Vidal Y., Volkow P., Pezzarossi H., et al. Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk. J Pediatr 1990, 116(May (5)):707-713.
79. Holmgren J., Svennerholm A.M., Ahren C. Nonimmunoglobulin fraction of human milk inhibits bacterial adhesion (hemagglutination) and enterotoxin binding of Escherichia coli and Vibrio cholerae. Infect Immun 1981, 33(July (1)):136-141.
80. Otnaess A.B., Laegreid A., Ertresvag K. Inhibition of enterotoxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk. Infect Immun 1983, 40(May (2)):563-569.
81. Wilkinson H.W. Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic. Infect Immun 1975, 11(April (4)):845-852.
82. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci 2010, 86(7):731-747.
83. Pritchard D.G., Gray B.M., Egan M.L. Murine monoclonal antibodies to type Ib polysaccharide of group B streptococci bind to human milk oligosaccharides. Infect Immun 1992, 60(April (4)):1598-1602.